AMICUS THERAPEUTICS INC. - COMMON STOCK

Amicus Therapeutics Announces FDA Approval and Launch of New Treatment for Pompe Disease

28 9 2023 09:41:45 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2023

01 9 2023 06:00:18 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Presentation and Posters at the SSIEM Annual Symposium 2023

29 8 2023 06:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Appoints Simon Harford as Chief Financial Officer

21 8 2023 06:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the United Kingdom

15 8 2023 06:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: AMICUS THERAPEUTICS INC. - COMMON STOCK

09 8 2023 08:45:02 提供 NetDania Notify

NetDania - New 12 months High: AMICUS THERAPEUTICS INC. - COMMON STOCK

08 8 2023 15:15:05 提供 NetDania Notify

Amicus Therapeutics Announces Second Quarter 2023 Financial Results and Corporate Updates

08 8 2023 06:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Second Quarter 2023 Financial Results on August 8, 2023

31 7 2023 06:00:00 提供 Nasdaq GlobeNewswire

NetDania - New 12 months High: AMICUS THERAPEUTICS INC. - COMMON STOCK

21 7 2023 08:48:54 提供 NetDania Notify

Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the European Union

27 6 2023 06:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces First Quarter 2023 Financial Results and Corporate Updates

10 5 2023 06:00:02 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Bank of America 2023 Health Care Conference

02 5 2023 06:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Announce First Quarter 2023 Financial Results on May 10, 2023

01 5 2023 06:00:01 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Receives Positive CHMP Opinion for Opfolda® (miglustat) for Late-Onset Pompe Disease

26 4 2023 12:00:33 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces European Commission Approval for Pombiliti™ in Patients with Late-Onset Pompe Disease

27 3 2023 06:00:09 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Full-Year 2022 Financial Results and Corporate Updates

01 3 2023 06:00:02 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Present at the Cowen 43rd Annual Health Care Conference

27 2 2023 06:00:00 提供 Nasdaq GlobeNewswire

Amicus Therapeutics Announces Positive Long-Term Data from Phase 3 Open-label Extension Study of AT-GAA in Late-Onset Pompe Disease at the 19th Annual WORLDSymposium™ 2023

22 2 2023 16:00:08 提供 Nasdaq GlobeNewswire

Amicus Therapeutics to Announce Full-Year 2022 Financial Results on March 1, 2023

14 2 2023 06:00:00 提供 Nasdaq GlobeNewswire